US 9221800
Isoxazole treatments for diabetes
granted A61KA61K31/415A61K31/42
Quick answer
US patent 9221800 (Isoxazole treatments for diabetes) held by The Board of Regents of the University of Texas System expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K31/415, A61K31/42, A61K31/422, A61P